Login to Your Account



R&D Costs, Reimbursement Challenges in War Against Bugs

By Mari Serebrov
Washington Editor

Thursday, January 31, 2013
Hoping to gain some ground in an all-out war against superbugs, the FDA is taking the first steps toward creating an approval shortcut for new antimicrobials with a public hearing Feb. 4.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription